000			01309nam a2200229Ia 4500
008			241008s9999||||xx |||||||||||||| ||und||
022			_a0034-6535
100			_aGoodkin-Gold, Matthew _9122803
245		0	_aOptimal Vaccine Subsidies for Epidemic Diseases
260			_bThe Review of Economics and Statistics
260			_c2024
300			_a895-909
520			_aWe analyze optimal vaccine subsidies in a model integrating disease epidemiology into a market with rational economic agents. The focus is on an intensive vaccine campaign to quell an epidemic in the short run. Across a range of market structures, positive vaccine externalities and optimal subsidies peak for diseases that spread quickly, but not so quickly that everyone is driven to be vaccinated. We assess the practical relevance of this peak-as well as the existence of increasing social returns to vaccination and optimality of universal vaccination-in calibrations to the COVID-19 pandemic.
650			_a Disease Epidemiology _9122804
650			_a Epidemic Diseases _937469
650			_a Vaccine Subsidies _9122805
650			_aCOVID-19 Pandemic
700			_a Kremer, Michael _9122806
700			_a Snyder, Christopher M. _9122807
700			_a Williams, Heidi _9122808
856			_uhttps://doi.org/10.1162/rest_a_01202
999			_c134358 _d134358